Axcelis Technologies/$ACLS

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Axcelis Technologies

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Ticker

$ACLS

Sector

Semiconductors
Primary listing

Employees

1,524

ACLS Metrics

BasicAdvanced
$2.6B
20.10
$4.25
-
-

What the Analysts think about ACLS

Analyst ratings (Buy, Hold, Sell) for Axcelis Technologies stock.

Bulls say / Bears say

Aftermarket (CS&I) revenue in Q3 2025 grew 26% year-on-year to $69.9 million, bolstering higher-margin, recurring service revenues (MarketScreener)
The company remained debt-free and repurchased $45 million of its own shares in Q2 2025, underscoring strong cash flow and management’s confidence in long-term fundamentals (PRNewswire)
Revenue recovered sequentially in Q3 2025 to $213.6 million, up 9.8% from Q2’s $194.5 million, indicating stabilization in customer demand amid the industry’s cyclical downturn (MarketScreener)
Analysts anticipate a 27.8% year-on-year drop in Q2 revenue to $185.14 million, reflecting continued weakness in customer spending for ion implantation equipment (Reuters)
Systems backlog has declined from $758.2 million in Q3 2024 to $484.5 million in Q3 2025, reducing near-term order visibility and signaling lower future revenue (MarketScreener)
Axcelis’ stock plunged 6.8% after Q4 2024 guidance for Q1 2025 revenue of $185 million and EPS of $0.38 fell well short of analyst forecasts, highlighting investor concern over the near-term outlook (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Nov 2025.

ACLS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ACLS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ACLS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs